Bruce R Murray

Title: Bruce R. Murray: Innovator in Mucolytic Therapies

Introduction

Bruce R. Murray is a notable inventor based in Tofield, Canada. He has made significant contributions to the field of respiratory therapies, particularly through his innovative use of inhaled gaseous nitric oxide. With a total of three patents to his name, Murray's work focuses on improving treatments for excess mucus accumulation in mammals.

Latest Patents

Murray's latest patents include methods and devices for treating excess mucus accumulation by administering gaseous inhaled nitric oxide or nitric oxide-releasing compounds. These methods serve as mucolytic agents or expectorants. The delivery of gaseous nitric oxide can be achieved nasally or orally, ideally coinciding with the mammal's inhalation or based on a synchronous parameter of the respiratory cycle. Therapeutic profiles can vary depending on the severity of mucus accumulation, with parameters including flow rate, duration of administration, number of breaths, and concentrations of therapeutic nitric oxide delivered to the airways.

Career Highlights

Throughout his career, Bruce R. Murray has worked with several companies, including Pulmonox Technologies Corporation and Advanced Inhalation Therapies Ltd. His innovative approaches have positioned him as a key figure in the development of respiratory therapies.

Collaborations

Murray has collaborated with notable individuals in his field, including Christopher C. Miller and Douglas R. Hole. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Bruce R. Murray's work in the field of mucolytic therapies showcases his dedication to improving respiratory health. His innovative patents and collaborations highlight his significant impact on the medical community.